Trial Details
COMPLETEDBasic Information
| Clinical ID | c2933 |
|---|---|
| Identifier | NCT02765256 |
| Trial Title | Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Fluconazole|DRUG: Vancomycin|DRUG: Neomycin|DRUG: Ciprofloxacin|DRUG: Polyethylene Glycol 3350|DRUG: Promethazine|DRUG: Fluconazole placebo |
Participant Information
| Sponsor | University of Pennsylvania |
|---|---|
| City | Philadelphia |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2016-08 |
|---|---|
| Primary Completion Date | 2018-12 |
| Completion Date | 2018-12 |